Warning: The NCBI web site requires JavaScript to function. more...
Stereotyping and the treatment of missing data for drug and alcohol clinical trials.
Arndt S.
Subst Abuse Treat Prev Policy. 2009 Feb 18;4:2.
Related citations
Dropouts and missing data in psychiatric clinical trials.
Potkin SG, Siu CO.
Am J Psychiatry. 2009 Nov;166(11):1295; author reply 1295-6. No abstract available.
Modern statistical methods for handling missing repeated measurements in obesity trial data: beyond LOCF.
Gadbury GL, Coffey CS, Allison DB.
Obes Rev. 2003 Aug;4(3):175-84.
The impact of loss to follow-up on hypothesis tests of the treatment effect for several statistical methods in substance abuse clinical trials.
Hedden SL, Woolson RF, Carter RE, Palesch Y, Upadhyaya HP, Malcolm RJ.
J Subst Abuse Treat. 2009 Jul;37(1):54-63. Epub 2008 Nov 13.
An alternative way to classify missing data mechanism in clinical trials--a dialogue on missing data.
Wei L.
J Biopharm Stat. 2011 Mar;21(2):355-61.
Comparison of data analysis strategies for intent-to-treat analysis in pre-test-post-test designs with substantial dropout rates.
Salim A, Mackinnon A, Christensen H, Griffiths K.
Psychiatry Res. 2008 Sep 30;160(3):335-45. Epub 2008 Aug 20.
Statistical outcome of random versus selected withdrawal of dental implants.
Herrrmann I, Lekholm U, Holm S.
Int J Prosthodont. 2003 Jan-Feb;16(1):25-30.
Assessing missing data assumptions in longitudinal studies: an example using a smoking cessation trial.
Yang X, Shoptaw S.
Drug Alcohol Depend. 2005 Mar 7;77(3):213-25.
Baseline observation carry forward: reasoning, properties, and practical issues.
Shao J, Jordan DC, Pritchett YL.
J Biopharm Stat. 2009 Jul;19(4):672-84.
Testing for treatment differences with dropouts present in clinical trials--a composite approach.
Troendle JF.
Stat Med. 1998 May 15;17(9):1062-4. No abstract available.
Reading reports of clinical trial results.
Kane JM.
J Clin Psychiatry. 2005 May;66(5):653. No abstract available.
Methods for the analysis of binary outcome results in the presence of missing data.
Delucchi KL.
J Consult Clin Psychol. 1994 Jun;62(3):569-75.
MMRM versus MI in dealing with missing data--a comparison based on 25 NDA data sets.
Siddiqui O.
J Biopharm Stat. 2011 May;21(3):423-36.
Selection bias in observational and experimental studies.
Ellenberg JH.
Stat Med. 1994 Mar 15-Apr 15;13(5-7):557-67. Review.
Adjusting for drop-out in clinical trials with repeated measures: design and analysis issues.
Wu MC, Albert PS, Wu BU.
Stat Med. 2001 Jan 15;20(1):93-108.
A graphical assessment of the potential impact of losses to follow-up on the validity of study results. The Terry Beirn Community Programs for Clinical Research on AIDS.
Matts JP, Launer CA, Nelson ET, Miller C, Dain B.
Stat Med. 1997 Sep 15;16(17):1943-54.
Dropout rates for intent-to-treat and per protocol analyses.
Stewart WC, Jackson AL, Jenkins JN.
Am J Ophthalmol. 2004 Apr;137(4):639-45.
A bias correction in testing treatment efficacy under informative dropout in clinical trials.
Kong F, Chen YF, Jin K.
J Biopharm Stat. 2009 Nov;19(6):980-1000.
Addressing missing data in clinical trials.
van der Laan M, Lorenz TJ.
Ann Intern Med. 2011 Jul 19;155(2):135. No abstract available.
Stigma, social inequality and alcohol and drug use.
Room R.
Drug Alcohol Rev. 2005 Mar;24(2):143-55. Review.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on